In triple-seronegative myasthenia gravis that is anti-AChR-MuSK-LRP4 antibody-negative, ocular muscle involvement (33%) manifested more significantly than AChR MG (13%) (p = 0.0250) (Morena et al., 2022). The gene discussed is LRP4; the disease is myasthenia gravis.